Bellevue Life Sciences Acquisition Corp. (BLAC)

USD 11.32

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020
Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses 1.83 Million 35.38 Thousand 3308.00 23.81 Thousand
Selling, General and Administrative Expenses 1.83 Million 35.38 Thousand 3308.00 23.81 Thousand
Research and Development Expenses - - - -
Other Expenses - - - -
Cost and Expenses 1.83 Million 35.38 Thousand 3308.00 23.81 Thousand
Operating Income -1.83 Million -35.38 Thousand -3308.00 -23.81 Thousand
Interest Expense - - - -
Income Tax Expense 540.81 Thousand -228.48 Thousand -236.55 Thousand -206.29 Thousand
Earnings before Tax 944.59 Thousand -35.38 Thousand -3308.00 -23.81 Thousand
Net Income 403.78 Thousand -35.38 Thousand -3308.00 -23.81 Thousand
Earnings Per Share Basic 0.07 -0.00 -0.00 -0.00
Earnings Per Share Diluted 0.07 -0.00 -0.00 -0.00
Weighted Average Shares Outstanding 5.62 Million 9.05 Million 7.93 Million 7.89 Million
Weighted Average Shares Outstanding (Diluted) 5.62 Million 9.05 Million 7.93 Million 7.89 Million
Gross Margin - - - -
EBIT Margin - - - -
Profit Margin - - - -
EBITDA 944.59 Thousand -35.38 Thousand -3308.00 -23.81 Thousand
Earnings Before Tax Margin - - - -

Income Statement Charts